Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Pediatr Dermatol ; 39(6): 923-926, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35973724

ABSTRACT

An electronic consultation (e-Consult) store-and-forward teledermatology program was implemented to improve access to dermatologic care in Maine. While initially designed to triage potential skin cancers, we found this program to be heavily used for pediatric patients, especially infants. Our findings suggest e-Consult expedites care for pediatric dermatology patients, particularly those with infantile hemangiomas. The addition of dermoscopy to e-Consult platforms has the potential to expand e-Consult effectiveness.


Subject(s)
Dermatology , Hemangioma, Capillary , Skin Diseases , Telemedicine , Infant , Humans , Child , Referral and Consultation , Electronics
3.
Cutis ; 108(5): 251-253, 2021 Nov.
Article in English | MEDLINE | ID: mdl-35100530

ABSTRACT

Giant hogweed (Heracleum mantegazzianum) is an invasive flowering weed that can reach a height of 13 feet. Although it is the appearance of the plant that can draw attention, contact with the sap in combination with exposure to the sun can result in severe phytophotodermatitis. Due to the growing prevalence of giant hogweed, the number of cases of H mantegazzianum-associated phytophotodermatitis in the United States is increasing. We report the case of a 27-year-old man who presented with a blistering rash on the neck and arms that developed 18 to 24 hours after trimming giant hogweed plants without photoprotection. A diagnosis of giant hogweed phytophotodermatitis should be considered for patients presenting with acute erythema and bullae in sun-exposed areas after exposure to the plant. Additionally, the public would benefit from education, especially during summer months, on identifying the plant and reducing phototoxin exposure to reduce the risk for phytophotodermatitis.


Subject(s)
Dermatitis, Phototoxic , Exanthema , Heracleum , Adult , Dermatitis, Phototoxic/etiology , Heracleum/adverse effects , Humans , Male
4.
Case Rep Transplant ; 2021: 8981429, 2021.
Article in English | MEDLINE | ID: mdl-34888111

ABSTRACT

Acute graft-versus-host disease (aGvHD) is a rare complication of liver transplantation associated with high morbidity and mortality. Death typically occurs due to complications related to severe infection, shock, and multiorgan failure. The clinical presentation involves dysfunction of multiple organ systems with overlapping symptoms that often results in a diagnostic delay. As there are a limited number of cases reported in the literature, there are no clear guidelines for treatment. Many different therapeutic measures have been utilized that target various immune system pathways, but steroids remain the first line of therapy. We report on two patients who developed aGvHD after liver transplantation who were treated with ruxolitinib, a novel Janus kinase 1/2 (JAK) inhibitor that has been shown to improve outcomes in steroid refractory cases of aGvHD after allogenic hematopoietic stem cell transplantation. We reviewed the literature to discuss various therapeutic options currently available for aGvHD after liver transplantation.

5.
BMJ Case Rep ; 13(4)2020 Apr 23.
Article in English | MEDLINE | ID: mdl-32332045

ABSTRACT

An 80-year-old woman presented with a several-year history of progressive hair loss and scalp pruritus. No other rashes or muscle weakness were noted on examination. Scalp biopsy showed interface dermatitis, dense perivascular and periadnexal lymphocytic infiltrate, mucin and scarring alopecia. Laboratory analysis did not show evidence of myositis. The patient was started on hydroxychloroquine for possible cutaneous lupus erythematosus. On follow-up, she presented with a new violaceous rash on the superior eyelids and a well-defined oval patch on the mid-hard palate suspicious for dermatomyositis. Myositis-specific autoantibodies revealed presence of anti-transcriptional intermediary factor-1γ (anti-TIF1γ) in the serum. Anti-TIF1γ autoantibody-positive dermatomyositis is a newly recognised subtype of dermatomyositis that is highly associated with amyopathic disease and has an increased risk of malignancy, making prompt diagnosis crucial. This case highlights the utility of a thorough oral exam in patients suspected to have connective tissue disease as the distinctive ovoid palatal patch is nearly pathognomonic for anti-TIF1γ dermatomyositis.


Subject(s)
Autoantibodies/blood , Dermatomyositis/diagnosis , Erythema/pathology , Exanthema/pathology , Palate, Hard/pathology , Aged, 80 and over , Dermatologic Agents/therapeutic use , Dermatomyositis/drug therapy , Diagnosis, Differential , Female , Humans , Methotrexate/therapeutic use , Transcription Factors/immunology
6.
Clin Dermatol ; 25(5): 434-42, 2007.
Article in English | MEDLINE | ID: mdl-17870521

ABSTRACT

Laser therapy is one of the fastest expanding and most exciting fields in dermatology. From its theoretical beginnings in Einstein's imagination, lasers have come to be used in treatments for conditions ranging from skin malignancy and acne to hirsutism and photoaging. We will briefly review the evolution of laser treatment, with a focus on the recent developments surrounding the new millennium.


Subject(s)
Dermatology/methods , Laser Therapy , Lasers/history , Skin Diseases/therapy , Dermatology/trends , Equipment Design , Hair Removal/methods , History, 20th Century , Humans , Laser Therapy/history , Laser Therapy/methods , Laser Therapy/trends , Photochemotherapy/methods , Phototherapy/methods , Rejuvenation
SELECTION OF CITATIONS
SEARCH DETAIL